相关实验视频

Updated: Jul 14, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

索福斯布维尔和NITD008在肝外神经细胞中对HEV的表现

Michelle Jagst¹, André Gömer², Daniel Todt³

¹Department of Molecular and Medical Virology, Ruhr-Universität Bochum, Bochum, Germany; University of Veterinary Medicine Hannover, Institute of Virology, Hannover, Germany.

Antiviral research

|June 2, 2024

概括

肝炎E病毒 (HEV) 药物,如索福斯布维尔在脑细胞中的有效性低于肝细胞. 这一发现对于开发针对肝脏以外的HEV的新疗法至关重要.

科学领域:

病毒学和传染病学.
肝炎E病毒 (HEV) 研究研究
神经科学与药物有效性

背景情况:

肝炎E病毒 (HEV) 导致全球显著的感染和死亡率,在孕妇和免疫功能低下的人群中造成严重的后果.
高血压病毒感染与神经系统并发症有关,强调需要了解病毒行为和治疗疗效超出肝脏范围.
对于HEV的现有治疗方法是有限的;重新定位的药物,如索福斯布维尔显示出希望,但需要进一步调查肝外活性.

研究的目的:

评估重新定位的病毒聚合酶抑制剂,特别是索福斯布维尔和NITD008,在神经元衍生细胞系中对E型肝炎病毒 (HEV) 的疗效.
确定这些抗病毒药物在肝外复制部位,特别是神经组织中的功效.

主要方法:

利用各种神经元衍生细胞系来模拟肝外HEV复制.
在这些神经元细胞模型中评估了sofosbuvir和NITD008的抗病毒疗效.
在神经元细胞中比较药物的疗效与在肝细胞中确定的疗效.

主要成果:

与肝细胞相比,索福斯布维尔和NITD008在抑制神经元细胞内的HEV复制方面表现出较低的疗效.
索福斯布维尔在神经元细胞系中表现出特别减少的功效.
这些发现表明,在HEV复制的肝外部位的药物有效性差异.

结论:

对E型肝炎病毒 (HEV) 的直接作用抗病毒药物的疗效在神经元细胞中可能明显低于肝细胞.
对HEV的药物开发应该考虑抗病毒药物在肝外复制部位 (如大脑) 的功效降低.
需要进一步的研究,以优化HEV治疗神经症状和慢性感染在免疫功能低下的患者.

关键词:

抗病毒药物抗病毒药物肝炎E病毒的感染.在NITD008中,它是NITD008.神经元细胞是一种神经元细胞.索福斯布维尔 (Sofosbuvir) 是一种药物.

更多相关视频

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

相关概念视频

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...